Further insights into the anti-PF4/heparin IgM immune response

Summary Anti-platelet factor 4 (PF4)/heparin antibodies are not only the cause of heparin-induced thrombocytopenia but might also play a role in the antibacterial host defence. Recently, marginal zone (MZ) B cells were identified to be crucial for anti-PF4/heparin IgG antibody production in mice. Combining human studies and a murine model of polymicrobial sepsis we further characterised the far less investigated anti-PF4/heparin IgM immune response. We detected anti-PF4/heparin IgM antibodies in the sera of paediatric patients < 6 months of age after cardiac surgery and in sera of splenectomised mice subjected to polymicrobial sepsis. In addition, PF4/heparin-specific IgM B cells were not only found in murine spleen, but also in peritoneum and bone marrow upon in vitro stimulation. Together, this indicates involvement of additional B cell populations, as MZ B cells are not fully developed in humans until the second year of life and are restricted to the spleen in mice. Moreover, PF4/heparin-specific B cells were detected in human cord blood upon in vitro stimulation and PF4-/- mice produced anti-PF4/heparin IgM antibodies after polymicrobial sepsis. In conclusion, the anti-PF4/heparin IgM response is a potential innate immune reaction driven by a B cell population distinct from MZ B cells. Supplementary Material to this article is available online at www.thrombosis-online.com.

[1]  T. Renné,et al.  Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria , 2015, Thrombosis and Haemostasis.

[2]  A. Greinacher.  CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia. , 2015, The New England journal of medicine.

[3]  R. Aster,et al.  Critical role of CD4 T cells in PF4/heparin antibody production in mice. , 2015, Blood.

[4]  A. Greinacher,et al.  New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells. , 2014, Thrombosis research.

[5]  T. Kohlmann,et al.  Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis. , 2013, Blood.

[6]  J. Sunyer,et al.  Evolution of B cell immunity. , 2013, Annual review of animal biosciences.

[7]  Xiaoming Zhang.  Regulatory functions of innate-like B cells , 2013, Cellular and Molecular Immunology.

[8]  Irene Puga,et al.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes , 2013, Nature Reviews Immunology.

[9]  G. Arepally,et al.  Critical role for mouse marginal zone B cells in PF4/heparin antibody production. , 2012, Blood.

[10]  S. Hammerschmidt,et al.  Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes. , 2012, Blood.

[11]  Derek D. Jones,et al.  Antigen-Driven Induction of Polyreactive IgM during Intracellular Bacterial Infection , 2012, The Journal of Immunology.

[12]  E. Montecino-Rodriguez,et al.  B-1 B cell development in the fetus and adult. , 2012, Immunity.

[13]  N. Baumgarth,et al.  B‐1 cells in the bone marrow are a significant source of natural IgM , 2012, European journal of immunology.

[14]  T. Ittermann,et al.  Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease. , 2011, Blood.

[15]  M. Vlková,et al.  Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. , 2011, Vaccine.

[16]  T. Ittermann,et al.  Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. , 2011, Blood.

[17]  T. Rothstein,et al.  Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of experimental medicine.

[18]  A. Greinacher,et al.  Studies of the anti–platelet factor 4/heparin immune response: adapting the enzyme‐linked immunosorbent spot assay for detection of memory B cells against complex antigens , 2010, Transfusion.

[19]  T. Ittermann,et al.  Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive , 2010, Journal of thrombosis and haemostasis : JTH.

[20]  G. Arepally,et al.  Optimization of a murine immunization model for study of PF4/heparin antibodies , 2009, Journal of thrombosis and haemostasis : JTH.

[21]  N. Baumgarth,et al.  Dual role for B-1a cells in immunity to influenza virus infection , 2008, The Journal of experimental medicine.

[22]  A. Greinacher,et al.  Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes , 2007, Journal of thrombosis and haemostasis : JTH.

[23]  A. Greinacher,et al.  Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia , 2006, European journal of haematology.

[24]  Y. Fukunaga,et al.  Implications for Induction of Autoimmunity via Activation of B-1 Cells by Helicobacter pylori Urease , 2006, Infection and Immunity.

[25]  Emily K. E. McCracken,et al.  PF4/heparin complexes are T cell-dependent antigens. , 2005, Blood.

[26]  S. Pillai,et al.  Marginal zone B cells. , 2005, Annual review of immunology.

[27]  L. Rauova,et al.  Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. , 2004, Blood.

[28]  T. Warkentin,et al.  Heparin‐induced thrombocytopenia: pathogenesis and management , 2003, British journal of haematology.

[29]  H. Wardemann,et al.  B-1a B Cells that Link the Innate and Adaptive Immune Responses Are Lacking in the Absence of the Spleen , 2002, The Journal of experimental medicine.

[30]  J. Kearney,et al.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.

[31]  Y. Gruel,et al.  Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia. , 1999, Circulation.

[32]  T. Ortel,et al.  Heparin-induced thrombocytopenia. , 2006, Seminars in hematology.

[33]  B. Chong,et al.  Heparin-induced Thrombocytopenia: IgG Binding to PF4-Heparin Complexes in the Fluid Phase and Cross-reactivity with Low Molecular Weight Heparin and Heparinoid , 1998, Thrombosis and Haemostasis.

[34]  R. Aster,et al.  Characterization of the humoral immune response in heparin‐induced thrombocytopenia , 1997, American journal of hematology.

[35]  L. Herzenberg,et al.  De novo development and self-replenishment of B cells. , 1995, International immunology.

[36]  A. Kántor,et al.  A new nomenclature for B cells. , 1991, Immunology today.

[37]  S. Poppema,et al.  Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. , 1989, Journal of immunology.